Compounds > misonidazole
Page last updated: 2024-08-22

misonidazole and Breast Neoplasms

misonidazole has been researched along with Breast Neoplasms in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19906 (42.86)18.7374
1990's3 (21.43)18.2507
2000's0 (0.00)29.6817
2010's5 (35.71)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Asano, A; Hasebe, T; Hirokawa, E; Kuji, I; Osaki, A; Saeki, T; Shimada, H; Sugitani, I; Takeuchi, H; Ueda, S; Yamane, T1
Sorace, AG; Syed, AK; Whisenant, JG; Woodall, R; Yankeelov, TE1
Bernards, N; Beynel, A; Boisgard, R; Bouet, S; Buvat, I; Kuhnast, B; Tavitian, B; Thézé, B1
Desco, M; Hernández-Agudo, E; Hidalgo, M; Lopez-Casas, PP; Megías, D; Mondejar, T; Mouron, S; Mulero, F; Quintela-Fandino, M; Sanchez, J; Soto-Montenegro, ML1
Cheng, J; Lei, L; Liu, G; Pan, L; Shao, Z; Sun, Y; Wang, X; Xu, J; Zhang, Y1
Dische, S; Minchinton, A; Rich, TA; Saunders, MI; Stratford, MR1
Bennett, MH; Dische, S; Hauck, J; Minchinton, AI; Riley, PJ; Saunders, MI; Stratford, MR1
Kogelnik, HD; Mamoli, B; Reinartz, G; Seitz, W; Stark, H; Szepesi, T; Wessely, P; Wurst, F1
Cherif, A; Harrod, VL; Inoue, T; Kim, CG; Kim, EE; Kuang, LR; Newman, RA; Nornoo, A; Podoloff, DA; Wallace, S; Yang, DJ1
Chinje, EC; Harris, AL; Patterson, AV; Saunders, MP; Strafford, IJ; Talbot, DC1
Ash, DV; Bugden, RD; Smith, MR1
Asbell, S; Isaacson, S; Komarnicky, LT; Martz, K; Phillips, TL; Urtasun, R1
Baillet, F; Boisserie, G; Dessard-Diana, B; Housset, M1
Chang, CH; Durbin, LM; Komaki, RU; Leibel, SA; Lipshutz, J; Massullo, V; Order, SE; Pajak, TF; Phillips, TL; Wasserman, TH1

Trials

3 trial(s) available for misonidazole and Breast Neoplasms

ArticleYear
A randomized phase III protocol for the evaluation of misonidazole combined with radiation in the treatment of patients with brain metastases (RTOG-7916).
    International journal of radiation oncology, biology, physics, 1991, Volume: 20, Issue:1

    Topics: Adenocarcinoma; Adult; Aged; Brain Neoplasms; Breast Neoplasms; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Humans; Lung Neoplasms; Male; Middle Aged; Misonidazole; Prospective Studies; Radiation-Sensitizing Agents; Survival Analysis

1991
Positive clinical experience with misonidazole in brachytherapy and external radiotherapy.
    International journal of radiation oncology, biology, physics, 1989, Volume: 16, Issue:4

    Topics: Brachytherapy; Breast Neoplasms; Combined Modality Therapy; Female; Humans; Misonidazole; Otorhinolaryngologic Neoplasms; Radiotherapy Dosage

1989
A comparison of misonidazole sensitized radiation therapy to radiation therapy alone for the palliation of hepatic metastases: results of a Radiation Therapy Oncology Group randomized prospective trial.
    International journal of radiation oncology, biology, physics, 1987, Volume: 13, Issue:7

    Topics: Alkaline Phosphatase; Breast Neoplasms; Colonic Neoplasms; Female; Humans; Liver Neoplasms; Lung Neoplasms; Male; Misonidazole; Prognosis

1987

Other Studies

11 other study(ies) available for misonidazole and Breast Neoplasms

ArticleYear
Intracellular hypoxia measured by
    Breast cancer research : BCR, 2018, 07-27, Volume: 20, Issue:1

    Topics: Adult; Aged; Breast; Breast Neoplasms; Cell Hypoxia; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Misonidazole; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Receptors, Estrogen

2018
Characterizing Trastuzumab-Induced Alterations in Intratumoral Heterogeneity with Quantitative Imaging and Immunohistochemistry in HER2+ Breast Cancer.
    Neoplasia (New York, N.Y.), 2019, Volume: 21, Issue:1

    Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Diagnostic Imaging; Disease Models, Animal; Female; Humans; Image Processing, Computer-Assisted; Immunohistochemistry; Magnetic Resonance Imaging; Mice; Misonidazole; Positron-Emission Tomography; Receptor, ErbB-2; Reproducibility of Results; Trastuzumab; Xenograft Model Antitumor Assays

2019
Monitoring therapeutic efficacy of sunitinib using [(18)F]FDG and [(18)F]FMISO PET in an immunocompetent model of luminal B (HER2-positive)-type mammary carcinoma.
    BMC cancer, 2015, Jul-22, Volume: 15

    Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Proliferation; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Glucose Transporter Type 1; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Indoles; Mice; Misonidazole; Positron-Emission Tomography; Pyrroles; Sunitinib

2015
Monitoring vascular normalization induced by antiangiogenic treatment with (18)F-fluoromisonidazole-PET.
    Molecular oncology, 2016, Volume: 10, Issue:5

    Topics: Angiogenesis Inhibitors; Animals; Antimetabolites, Antineoplastic; Benzimidazoles; Breast; Breast Neoplasms; Cell Hypoxia; Cell Line, Tumor; Deoxycytidine; Female; Fluorine Radioisotopes; Gemcitabine; Humans; Mice; Mice, Nude; Misonidazole; Neovascularization, Pathologic; Pancreas; Pancreatic Neoplasms; Positron-Emission Tomography; Quinolones

2016
18F-fluoromisonidazole PET/CT: a potential tool for predicting primary endocrine therapy resistance in breast cancer.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2013, Volume: 54, Issue:3

    Topics: Aged; Aged, 80 and over; Aromatase Inhibitors; Breast Neoplasms; Drug Resistance, Neoplasm; Estrogen Receptor alpha; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Ki-67 Antigen; Letrozole; Middle Aged; Misonidazole; Multimodal Imaging; Neoplasms, Hormone-Dependent; Nitriles; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Triazoles

2013
A serial study of the concentration of misonidazole in human tumors correlated with histologic structure.
    International journal of radiation oncology, biology, physics, 1981, Volume: 7, Issue:2

    Topics: Adenocarcinoma; Biopsy; Breast Neoplasms; Female; Humans; Male; Misonidazole; Necrosis; Nitroimidazoles; Radiotherapy Dosage

1981
The concentration of desmethylmisonidazole in human tumours and in cerebrospinal fluid.
    British journal of cancer, 1981, Volume: 43, Issue:3

    Topics: Breast Neoplasms; Female; Humans; Misonidazole; Necrosis; Neoplasms; Nitroimidazoles; Radiation-Sensitizing Agents; Time Factors; Uterine Cervical Neoplasms

1981
[Clinical experience with daily doses of misonidazole (author's transl)].
    Strahlentherapie, 1980, Volume: 156, Issue:11

    Topics: Adult; Aged; Breast Neoplasms; Female; Genital Neoplasms, Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Misonidazole; Nervous System; Nitroimidazoles; Time Factors

1980
Development of new markers for hypoxic cells: [131I]Iodomisonidazole and [131I]Iodoerythronitroimidazole.
    Journal of drug targeting, 1996, Volume: 4, Issue:1

    Topics: Animals; Breast Neoplasms; Cell Hypoxia; Female; Iodine Radioisotopes; Lung Neoplasms; Mice; Mice, Inbred BALB C; Misonidazole; Neoplasms; Nitroimidazoles; Radiation-Sensitizing Agents; Radionuclide Imaging; Rats; Rats, Inbred F344; Tissue Distribution; Tumor Cells, Cultured

1996
Overexpression of human NADPH:cytochrome c (P450) reductase confers enhanced sensitivity to both tirapazamine (SR 4233) and RSU 1069.
    British journal of cancer, 1997, Volume: 76, Issue:10

    Topics: Antineoplastic Agents; Breast Neoplasms; Female; Humans; Misonidazole; NADPH-Ferrihemoprotein Reductase; Radiation-Sensitizing Agents; Tirapazamine; Transfection; Triazines; Tumor Cells, Cultured

1997
Distribution of misonidazole in human tumours and normal tissues.
    British journal of cancer, 1979, Volume: 39, Issue:5

    Topics: Brain Neoplasms; Breast Neoplasms; Female; Genital Neoplasms, Female; Humans; Male; Misonidazole; Neoplasms; Nitroimidazoles; Thyroid Diseases; Tissue Distribution; Urinary Bladder Neoplasms

1979